icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
San Francisco
November 2018
Back grey_arrow_rt.gif
 
 
 
NGM282 Rapidly Improves NAFLD Activity Score (NAS) and Fibrosis in 12 Weeks in Patients with Biopsy-Confirmed Nonalcoholic Steatohepatitis(NASH) Results of a Phase 2 Multi-Center Dose Finding Study
 
 
  Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
 
Stephen A. Harrison, James F. Trotter, Angelo H. Paredes, Cynthia D. Guy, Mustafa R. Bashir, Mark J. Jaros, Rajarshi Banerjee, Bryan A. Baxter, Lei Ling, Stephen J. Rossi, Alex M. DePaoli

1213181

1213182

1213183

1213184

1213185

1213186

1213187